Search alternatives:
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
significantly a » significantly _ (Expand Search), significantly i (Expand Search), significantly vary (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significantly improved » significantly increased (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
significantly a » significantly _ (Expand Search), significantly i (Expand Search), significantly vary (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
41
-
42
-
43
-
44
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
45
HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters
Published 2025“…</p><p dir="ltr">Compared to the ECIB algorithm and previous approaches, HDECO achieved significant improvements:</p><ul><li><b>Up to 10% reduction in energy consumption</b></li><li><b>8% decrease in overall execution cost</b></li><li><b>Better real execution time and fewer unnecessary migrations</b></li></ul><p dir="ltr">This makes HDECO an effective and lightweight solution for instance-intensive cloud workflows.…”
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
58
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
59
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
60
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”